|
US3342824A
(en)
*
|
1964-12-07 |
1967-09-19 |
Lilly Co Eli |
Normorphines
|
|
GB1123768A
(en)
*
|
1966-07-29 |
1968-08-14 |
Smith Kline French Lab |
New thebaine and oripavine derivatives and processes for preparing the same
|
|
US3466277A
(en)
*
|
1966-12-13 |
1969-09-09 |
Boehringer Sohn Ingelheim |
N-allylic cyclohexyl lower alkyl normorphines
|
|
US3905981A
(en)
*
|
1973-10-12 |
1975-09-16 |
Research Corp |
N-dealkylation of tertiary amines
|
|
NO802139L
(no)
*
|
1979-08-09 |
1981-02-10 |
Mallinckrodt Inc |
Utgangsforbindelser for fremstilling av morfinderivater, samt fremgangsmaate til fremstilling av utgangsforbindelsene
|
|
US4613668A
(en)
*
|
1983-12-22 |
1986-09-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
|
|
US4722928A
(en)
*
|
1985-12-02 |
1988-02-02 |
E. I. Du Pont De Nemours And Company |
N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes
|
|
US4990617A
(en)
*
|
1985-12-02 |
1991-02-05 |
E. I. Du Pont De Nemours And Company |
N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans and derivatives
|
|
US5668285A
(en)
*
|
1986-10-31 |
1997-09-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
|
|
DE69033035T2
(de)
*
|
1989-10-16 |
1999-08-05 |
The United States of America, represented by the Secretary, U.S. Department of Commerce, Washington, D.C. |
Totale synthese von northebain-, normorphin-, noroxymorphon-enantiomeren und -derivaten via n-nor-zwischenverbindungen
|
|
US5028612A
(en)
*
|
1990-03-22 |
1991-07-02 |
Hillel Glover |
Method for treating emotional numbness
|
|
MXPA05009757A
(es)
*
|
2003-03-13 |
2005-12-05 |
Controlled Chemicals Inc |
Conjugados de oxicodona con menor potencial de abuso y duracion de accion extendida.
|
|
EP1782834A3
(en)
*
|
2003-03-13 |
2007-08-01 |
Controlled Chemicals, Inc. |
Oxycodone conjugates with lower abuse potential and extended duration of action
|
|
DE602006019246D1
(de)
*
|
2005-06-16 |
2011-02-10 |
Mallinckrodt Inc |
Synthetische route zu 14-hydroxylopiaten über 1-halogenthebain oder analoga
|
|
JP2010510329A
(ja)
*
|
2006-11-22 |
2010-04-02 |
プロジェニックス ファーマスーティカルス インコーポレーテッド |
７，８−飽和−４，５−エポキシ−モルフィナニウム類似体
|
|
PL2125824T5
(pl)
*
|
2007-03-23 |
2024-11-04 |
SpecGx LLC |
Ulepszony sposób wytwarzania oksymorfonu z oripawiny
|
|
MX2009011020A
(es)
|
2007-04-12 |
2009-10-30 |
Nsab Af Neurosearch Sweden Ab |
Derivados de n-oxido y/o di-n-oxido de los estabilizadores/modulad ores del receptor de dopamina que exhiben perfiles mejorados de los efectos secundarios cardiovasculares.
|
|
WO2008130553A1
(en)
*
|
2007-04-16 |
2008-10-30 |
Mallinckrodt Inc. |
Novel opiate reduction utilizing catalytic hydrogen transfer reaction
|
|
EP2222677A1
(en)
|
2007-12-17 |
2010-09-01 |
Mallinckrodt Inc. |
N-demethylation of n-methyl morphinans
|
|
JP5688974B2
(ja)
*
|
2007-12-17 |
2015-03-25 |
マリンクロッド エルエルシー |
（＋）−オピエートの生成のためのプロセスおよび化合物
|
|
CN102227433B
(zh)
*
|
2008-09-30 |
2015-01-07 |
马林克罗特有限公司 |
烷基化吗啡喃衍生物的仲胺基团的方法
|
|
WO2011008636A1
(en)
*
|
2009-07-15 |
2011-01-20 |
Mallinckrodt Inc. |
3-oxy-hydromorphone derivatives
|